Showing 521 - 540 results of 6,525 for search '"cardiovascular"', query time: 0.07s Refine Results
  1. 521
  2. 522

    Acute myocarditis after the third dose of COVID‐19 mRNA‐1273 vaccine by Takayuki Yamada

    Published 2023-05-01
    Subjects: “…cardiovascular medicine…”
    Get full text
    Article
  3. 523
  4. 524

    Triglyceride levels and its association with all-cause mortality and cardiovascular outcomes among patients with heart failure by Qing-Wen Ren, Tiew-Hwa Katherine Teng, Wouter Ouwerkerk, Yi-Kei Tse, Christopher Tze Wei Tsang, Mei-Zhen Wu, Hung-Fat Tse, Adriaan A. Voors, Jasper Tromp, Carolyn S. P. Lam, Kai-Hang Yiu

    Published 2025-02-01
    “…In this population-based cohort (mean age: 71.4 ± 12.2 years, 51.8% male), the association between triglyceride levels and risk of all-cause mortality and cardiovascular disease was a U-shapedḍ curve. High triglyceride levels (≥3.0 mmol/L) were associated with atherosclerotic cardiovascular disease admission or death; conversely, lower triglyceride levels (<1.2 mmol/L) were associated with higher risks of HF readmission or death. …”
    Get full text
    Article
  5. 525

    Crosstalk between MicroRNAs and Peroxisome Proliferator-Activated Receptors and Their Emerging Regulatory Roles in Cardiovascular Pathophysiology by Yin-Feng Zhang, Hai-Ming Xu, Fei Yu, Man Wang, Meng-Yang Li, Tao Xu, Yan-Yan Gao, Jian-Xun Wang, Pei-Feng Li

    Published 2018-01-01
    “…Peroxisome proliferator-activated receptors (PPARs) play vital roles in cardiovascular pathophysiology, such as energy balance, cell proliferation/apoptosis, inflammatory response, and adipocyte differentiation. …”
    Get full text
    Article
  6. 526

    Cardiovascular Risk Factors and Distributions of the Ankle-Brachial Index among Type 2 Diabetes Mellitus Patients by Badaruddoza Doza, Manpreet Kaur, Sonia Chopra, Rohit Kapoor

    Published 2012-01-01
    “…The aim of present study is to observe the association between the levels of ankle-brachial index (ABI) and cardiovascular risk factors among people with type 2 diabetes mellitus in north India. …”
    Get full text
    Article
  7. 527
  8. 528
  9. 529
  10. 530

    Management of High Blood Pressure in Those without Overt Cardiovascular Disease Utilising Absolute Risk Scores by Mark R. Nelson

    Published 2011-01-01
    “…Increasing blood pressure has a continuum of adverse risk for cardiovascular events. Traditionally this single measure was used to determine who to treat and how vigorously. …”
    Get full text
    Article
  11. 531
  12. 532
  13. 533

    Cardiovascular Disease and Its Implication for Higher Catastrophic Health Expenditures Among Households in Sub-Saharan Africa by Folashayo Ikenna Peter Adeniji, Taiwo Akinyode Obembe

    Published 2023-03-01
    “…**Background:** Cardiovascular diseases (CVDs) impose an enormous and growing economic burden on households in sub-Saharan Africa (SSA). …”
    Get full text
    Article
  14. 534

    Effects of Tocotrienol on Cardiovascular Risk Markers in Patients With Chronic Kidney Disease: A Randomized Controlled Trial by Liana Trugilho, Lívia Alvarenga, Ludmila Cardozo, Bruna Paiva, Jessyca Brito, Isis Barboza, Jonatas Almeida, Juliana dos Anjos, Pramod Khosla, Marcelo Ribeiro-Alves, Denise Mafra

    Published 2025-01-01
    “…Tocotrienols, isomers of vitamin E, may provide an effective nutritional strategy to mitigate common cardiovascular risks such as dyslipidemia, inflammation, and oxidative stress in patients with chronic kidney disease (CKD). …”
    Get full text
    Article
  15. 535
  16. 536
  17. 537
  18. 538
  19. 539

    Cardiometabolic index and mortality risks: elevated cancer and reduced cardiovascular mortality risk in a large cohort by Junjie Wang, Li Xiao, Zhou Li

    Published 2024-12-01
    “…Notably, CMI was linked to an increased risk of cancer mortality (HR=1.02) and a reduced risk of cardiovascular disease mortality (HR=0.85). Furthermore, the average marginal effect of CMI on diabetes mortality was the largest (AME=0.499). …”
    Get full text
    Article
  20. 540